Companies / TransMedics Group, Inc. / Activity
Activity — TransMedics Group, Inc.
19 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Hernandez Gerardo Executive | Sell | Common Stock | $870.3K | -6K -28.70% | 14,689 0.04% of shares | medium |
| Mar 4, 2026 | Weill David Director | Sell | Common Stock | $524.3K | -4K -22.74% | 12,134 0.03% of shares | medium |
| Mar 4, 2026 | Hernandez Gerardo Executive | Exercise | Common Stock | $412.9K | +6K +40.25% | 20,601 0.06% of shares | low |
| Mar 2, 2026 | Corcoran Nicholas Executive | Sell | Common Stock | $412.6K | -3K -9.04% | 29,831 0.09% of shares | medium |
| Mar 4, 2026 | Hernandez Gerardo Executive | Sell | Common Stock | $194.9K | -1K -8.27% | 14,689 0.04% of shares | medium |
| Mar 4, 2026 | Lovell Stephanie Director | Sell | Common Stock | $178.5K | -1K -29.39% | 2,866 <0.01% of shares | medium |
| Jan 23, 2026 | Corcoran Nicholas Executive | Other | Common Stock | $133.1K | -984 -2.91% | 32,797 0.09% of shares | low |
| Mar 2, 2026 | Ranganath Anil P. Executive | Sell | Common Stock | $120.2K | -864 -6.19% | 13,091 0.04% of shares | medium |
| Mar 4, 2026 | Hernandez Gerardo Executive | Exercise | Common Stock | $102.1K | +1K +9.01% | 16,013 0.05% of shares | low |
| Mar 2, 2026 | Hernandez Gerardo Executive | Sell | Common Stock | $52.2K | -375 -2.49% | 14,689 0.04% of shares | low |
| Mar 4, 2026 | Weill David Director | Exercise | Common Stock | $50.7K | +4K +29.43% | 15,705 0.05% of shares | low |
| May 20, 2026 | Kania Edwin Director | Grant | Common Stock | $0 | +3K +1.12% | 263,732 0.76% of shares | low |
| May 20, 2026 | Tobin James R Director | Grant | Common Stock | $0 | +3K +71.99% | 6,981 0.02% of shares | low |
| May 20, 2026 | Raines Merilee Director | Grant | Common Stock | $0 | +3K +71.99% | 6,981 0.02% of shares | low |
| Feb 18, 2026 | Cecere Giovanni Executive | Grant | Common Stock | $0 | +11K +138.96% | 19,057 0.05% of shares | low |
| Mar 4, 2026 | Weill David Director | Exercise | Stock Option (Right to Buy) | — | -4K -71.42% | 1,429 <0.01% of shares | low |
| Mar 4, 2026 | Hernandez Gerardo Executive | Exercise | Stock Option (Right to Buy) | — | -6K -31.24% | 13,010 0.04% of shares | low |
| Mar 4, 2026 | Hernandez Gerardo Executive | Exercise | Stock Option (Right to Buy) | — | -1K -24.99% | 3,975 0.01% of shares | low |
| Feb 18, 2026 | Cecere Giovanni Executive | Grant | Stock Option (Right to Buy) | — | +17K | 16,734 0.05% of shares | low |